New biomaterial could change the way human tissue can be grown in the lab

Scientists at UNSW Sydney have created a new material that could change the way human tissue can be grown in the lab and used in medical procedures.

EMA validates Chiesi/Protalix’s submission of pegunigalsidase alfa

The EC granted marketing authorisation to the therapy to treat Fabry disease in adults in May 2023. Credit: bangoland/Shutterstock. The European Medicines Agency (EMA) has

December 10, 2024

Sequoia Project, AHIMA Launches Data Usability Initiative

What You Should Know: The Sequoia Project and AHIMA, today announced the launch of a new initiative called Data Usability Taking Root to make health

July 11, 2023

Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center | Psychedelic Invest

Tel Aviv, Israel / Vancouver, Canada, Feb. 01, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.